Почетна › Голема депресивна нарушување › Тексас
Клинички испитувања за Голема депресивна нарушување во Тексас
38 студии за Голема депресивна нарушување бараат учесници на локации во Тексас.
Градови во Тексас
- Houston16 студии
- Austin13 студии
- Grand Prairie11 студии
- Dallas9 студии
- Wichita Falls6 студии
- San Antonio5 студии
- Richardson5 студии
- Plano5 студии
- Fort Worth4 студии
- Sugar Land3 студии
Официјален текст на студијата (англиски)
ACP-211 Monotherapy for Major Depressive Disorder With Inadequate Antidepressant Response
- Baylor College of Medicine, Houston
- Olympus Clinical Research, LLC, Katy
- Family Psychiatry of The Woodlands, The Woodlands
Се регрутираФаза 2
Возраст од 18 до 65 · Сите полови · Ажурирано 5.10.2026 · NCT07284667A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder
- Adams Clinical Dallas, DeSoto
- Brain Health Consultants and TMS Center, Houston
- Flourish Research San Antonio, San Antonio
Се регрутираФаза 3
Возраст од 18 до 85 · Сите полови · Ажурирано 5.10.2026 · NCT06793397A Phase 3 Trial of DT120 for Major Depressive Disorder (Ascend)
- Austin Clinical Trial Partners, Austin
Се регрутираФаза 3
Возраст од 18 до 74 · Сите полови · Ажурирано 5.10.2026 · NCT07592689A Study of Brenipatide in Adult Participants With Major Depressive Disorder
- Adams Clinical Dallas, DeSoto
- Re:Cognition Health - Fort Worth, Fort Worth
- Consano Clinical Research, LLC, Shavano Park
Се регрутираФаза 3
Возраст од 18 до 75 · Сите полови · Ажурирано 5.10.2026 · NCT07412756A Study of Seltorexant as Monotherapy in Adults and Elderly Participants With Major Depressive Disorder
- Future Search Trials of Dallas, Dallas
Се регрутираФаза 3
Возраст од 18 до 74 · Сите полови · Ажурирано 1.10.2026 · NCT07573176A Study of Brenipatide (LY3537031) in Adult Participants With Major Depressive Disorder
- Gadolin Research, Beaumont
- Adams Clinical Dallas, DeSoto
- The University of Texas Rio Grande Valley, Harlingen
- и уште 1
Се регрутираФаза 3
Возраст од 18 до 75 · Сите полови · Ажурирано 1.10.2026 · NCT07775300Study of Lumateperone as Adjunctive Therapy in the Treatment of Patients With Major Depressive Disorder
- DM Clinical Research, Houston
- Pillar Clinical Research, LLC, Richardson
Се регрутираФаза 3
Возраст од 18 до 65 · Сите полови · Ажурирано 25.9.2026 · NCT05850689A Study to Evaluate the Efficacy and Safety of Esketamine for Reduction of Symptoms of Major Depressive Disorder
- John S Dunn Behavioral Sciences Center at UTHealth Houston, Houston
Се регрутираФаза 3
Возраст од 12 до 17 · Сите полови · Ажурирано 25.9.2026 · NCT07227454Phase 3 Study of Adjunctive Treatment With Seltorexant in Adult and Elderly Participants With Major Depressive Disorder and Insomnia Symptoms
- Houston Clinical Trials LLC, Bellaire
- North Texas Clinical Trials, Fort Worth
- Baylor College of Medicine, Houston
- и уште 1
Се регрутираФаза 3
Возраст од 18 до 74 · Сите полови · Ажурирано 25.9.2026 · NCT06559306A Study to Evaluate TNX-102 SL Monotherapy Versus Placebo in Participants With Major Depressive Disorder (MDD)
- Austin Clinical Trial Partners, Austin
- FutureSearch Trials of Dallas, Dallas
- Revival Research Institute, Llc - McKinney, Tx, McKinney
- и уште 1
Се регрутираФаза 2
Возраст 18 и постари · Сите полови · Ажурирано 25.9.2026 · NCT07621237Evaluation of Efficacy and Safety of Milsaperidone as Adjunctive Therapy in Patients With Major Depressive Disorder
- Vanda Investigational Site, Houston
- Vanda Investigational Site, Plano
- Vanda Investigational Site, Richardson
- и уште 1
Се регрутираФаза 3
Возраст од 18 до 65 · Сите полови · Ажурирано 24.9.2026 · NCT06830044A Study to Evaluate the Effectiveness of Valbenazine in Adult Participants With Tardive Dyskinesia (TD) Who Remain Symptomatic While Receiving or After Stopping a Vesicular Monoamine Transporter 2 (VMAT2) Inhibitor
- Neurocrine Clinical Site, Austin
Се регрутираФаза 4
Возраст 18 и постари · Сите полови · Ажурирано 18.9.2026 · NCT07105111Gamma Oscillations as a Prognostic Marker for Ketamine Therapy in Treatment Resistant Depression
- Wells Medicine, Houston
- Texas A&M (Houston Methodist Hospital Location), Houston
Се регрутираФаза 1Добредојдени се здрави волонтери
Возраст од 21 до 45 · Сите полови · Ажурирано 15.9.2026 · NCT06480201A Study to Evaluate the Efficacy and Safety of SPT-300 (GlyphAllo) in Participants With Major Depressive Disorder, With or Without Anxious Distress (BUOY-1 Study)
- Seaport Investigator Site, Dallas
- Seaport Investigator Site, Irving
- Seaport Investigator Site, Richardson
Се регрутираФаза 2
Возраст од 18 до 65 · Сите полови · Ажурирано 14.9.2026 · NCT07065240A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder (X-NOVA3)
- Austin Clinical Trial Partners, Austin
Се регрутираФаза 3
Возраст од 18 до 74 · Сите полови · Ажурирано 8.9.2026 · NCT07076407A Study to Evaluate the Effectiveness of DT-101 as an Adjunctive Treatment in Patients With Depression
- Draig Clinical Site, DeSoto
- Draig Clinical Site, Fort Worth
Се регрутираФаза 2
Возраст од 18 до 75 · Сите полови · Ажурирано 2.9.2026 · NCT07610473Treatment ResistAnt Depression Subcallosal CingulatE Network DBS (TRANSCEND)
- University of Texas Austin Dell Medical School, Austin
- University of Texas Southwestern Medical Center at Dallas, Dallas
- CHI St. Luke's Health Baylor College of Medicine Med. Ctr, Houston
- и уште 1
Се регрутира
Возраст од 22 до 70 · Сите полови · Ажурирано 28.8.2026 · NCT06423430A Study to Evaluate the Effectiveness of DT-101 in Patients With Depression
- Draig Clinical Site, Austin
- Draig Clinical Site, Austin
- Draig Clinical Site, DeSoto
- и уште 2
Се регрутираФаза 2
Возраст од 18 до 75 · Сите полови · Ажурирано 26.8.2026 · NCT07300969Accelerated Intermittent Theta Burst in Treatment-Naive Adolescents
- Dell Medical School at University of Texas at Austin, Austin
Се регрутира
Возраст од 13 до 20 · Сите полови · Ажурирано 19.8.2026 · NCT06523439NBI-1065845-MDD3025: Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
- Neurocrine Clinical Site, DeSoto
Се регрутираФаза 3
Возраст 18 и постари · Сите полови · Ажурирано 11.8.2026 · NCT06911112Zelquistinel or Placebo for the Reduction of Symptoms of Major Depressive Disorder
- Austin Clinical Trial Partners, Austin
- InSite Clinical Research, LLC, DeSoto
- Grayline Research Center, Wichita Falls
Се регрутираФаза 2
Возраст од 18 до 64 · Сите полови · Ажурирано 3.8.2026 · NCT06547489A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder
- Delricht Research - Plano, Plano
- Aim Trials, Llc, Plano
- Grayline Research Center, Wichita Falls
Се регрутираФаза 3
Возраст од 18 до 74 · Сите полови · Ажурирано 3.8.2026 · NCT06775379A Phase 2 Study of Zelquistinel or Placebo for the Reduction of Symptoms of Major Depressive Disorder
- Elevate Synapsis, LLC, Atascocita
- Synapsis Bio, Atascocita
- Adams Clinical Dallas, DeSoto
Се регрутираФаза 2
Возраст од 18 до 64 · Сите полови · Ажурирано 27.7.2026 · NCT07115329Clinical Assessment of Response in the Treatment of Depression With Daytime Sleepiness Using Solriamfetol
- Clinical Research Site, Austin
- Clinical Research Site, Bellaire
- Clinical Research Site, Dallas
- и уште 2
Се регрутираФаза 3
Возраст од 18 до 65 · Сите полови · Ажурирано 24.7.2026 · NCT07484217Long-Term Study to Assess the Safety and Tolerability of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
- Neurocrine Clinical Site, Bellaire
- Neurocrine Clinical Site, Dallas
- Neurocrine Clinical Site, DeSoto
- и уште 3
Се регрутираФаза 3
Возраст 18 и постари · Сите полови · Ажурирано 24.7.2026 · NCT06966401A Study to Evaluate the Maintenance Effect of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
- Neurocrine Clinical Site, Bellaire
- Neurocrine Clinical Site, Stafford
- Neurocrine Clinical Site, Wichita Falls
Се регрутираФаза 3
Возраст 18 и постари · Сите полови · Ажурирано 24.7.2026 · NCT07196501A Study to Assess Change in Disease Activity and Adverse Events of Oral Icalcaprant in Adult Participants With Major Depressive Disorder
- Austin Clinical Trial Partners /ID# 279321, Austin
- Community Clinical Research - Cross Park Drive /ID# 277935, Austin
- Houston Clinical Trials - Bellaire /ID# 277551, Bellaire
- и уште 1
Се регрутираФаза 2
Возраст од 18 до 65 · Сите полови · Ажурирано 15.6.2026 · NCT07276997Triage Survey for Psychiatry Research Eligibility
- Adams Clinical, Dallas, DeSoto
Се регрутираНабљудувачка студија
Возраст 18 и постари · Сите полови · Ажурирано 20.5.2026 · NCT05800925A Study to Assess the Efficacy, Safety and Tolerability of VLS-01 Buccal Film, Compared to Placebo in Patients With Treatment Resistant Depression (ELUMINA)
- Biobehavioral Research of Austin, Austin
- InSite Clinical Research, DeSoto
- Aim Trials, LLC, Plano
Се регрутираФаза 2
Возраст од 18 до 65 · Сите полови · Ажурирано 11.5.2026 · NCT06524830Self Neuro-modulation Therapy for Major Depressive Disorder (MDD) With Anhedonia
- Houston Center For Advanced Psychiatric Treatment, Houston
Се регрутира
Возраст од 22 до 75 · Сите полови · Ажурирано 1.5.2026 · NCT06982820Establishing Multimodal Brain Biomarkers for Treatment Selection in Depression
- Health Discovery Building (HDB), 1601 Trinity St., Bldg B., Z0600, Austin
Се регрутираФаза 4
Возраст од 18 до 65 · Сите полови · Ажурирано 1.5.2026 · NCT05892744Biomarkers/Biotypes, Course of Early Psychosis and Specialty Services
- University of Texas Southwestern Medical Center, Dallas
Се регрутираНабљудувачка студија
Возраст од 18 до 40 · Сите полови · Ажурирано 10.3.2026 · NCT06740383Study of ABX-002 for the Adjunctive Treatment of Major Depressive Disorder (AMPLIFY)
- Autobahn Site #153, Beaumont
- Autobahn Site #146, San Antonio
- Autobahn Site #144, Sherman
Се регрутираФаза 2
Возраст од 18 до 65 · Сите полови · Ажурирано 20.1.2026 · NCT06633016Psilocybin rTMS for Treatment Resistant Depression
- Health Discovery Building (HDB), 1601 Trinity St., Bldg B., Z0600, Austin
Се регрутираФаза 2
Возраст од 22 до 65 · Сите полови · Ажурирано 26.11.2025 · NCT06132178Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
- Neurocrine Clinical Site, Dallas
- Neurocrine Clinical Site, Houston
Се регрутираФаза 3
Возраст 18 и постари · Сите полови · Ажурирано 29.10.2025 · NCT06786624Study of ALTO-300 in MDD
- Site 347, Fort Worth
- Site 353, Plano
- Site 196, Richmond
Се регрутираФаза 2
Возраст од 18 до 70 · Сите полови · Ажурирано 24.7.2025 · NCT05922878A Study to Evaluate the Efficacy of AXS-05 Compared to Bupropion in Preventing the Relapse of Depressive Symptoms
- Clinical Research Site, Dallas
- Clinical Research Site, Dallas
- Clinical Research Site, Friendswood
- и уште 2
Се регрутираФаза 4
Возраст од 18 до 65 · Сите полови · Ажурирано 23.1.2025 · NCT06223880Neurobehavioral Therapy For Epilepsy And Major Depressive Disorder
- Michael E. DeBakey VA Medical Center, Houston
- The University of Texas health Science Center at Houston, Houston
Се регрутираДобредојдени се здрави волонтери
Возраст 18 и постари · Сите полови · Ажурирано 9.1.2025 · NCT06695767Од ClinicalTrials.gov, податоци преземени 6.10.2026. Секоја студија ги поставува своите услови за вклучување; тимот на студијата одлучува кој може да учествува.